Thomas H. Douglas

642 total citations
12 papers, 503 citations indexed

About

Thomas H. Douglas is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Thomas H. Douglas has authored 12 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 2 papers in Surgery. Recurrent topics in Thomas H. Douglas's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Urologic and reproductive health conditions (5 papers). Thomas H. Douglas is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Urologic and reproductive health conditions (5 papers). Thomas H. Douglas collaborates with scholars based in United States, Austria and Sweden. Thomas H. Douglas's co-authors include David G. McLeod, Judd W. Moul, William F. McCarthy, Gerald P. Murphy, Robert J. Barren, Roger R. Connelly, Sheila J. Erickson, F. K. Mostofi, Ted O. Morgan and Helmut Klocker and has published in prestigious journals such as Cancer, The Journal of Urology and Urology.

In The Last Decade

Thomas H. Douglas

12 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas H. Douglas United States 10 411 129 81 70 69 12 503
Per Å. Høisæter Norway 12 289 0.7× 64 0.5× 79 1.0× 89 1.3× 60 0.9× 28 455
W A Sakr United States 7 605 1.5× 102 0.8× 144 1.8× 123 1.8× 112 1.6× 10 738
Stephen A. Brassell United States 18 598 1.5× 147 1.1× 103 1.3× 92 1.3× 144 2.1× 28 736
Masatoshi Muramoto Japan 8 419 1.0× 80 0.6× 120 1.5× 112 1.6× 93 1.3× 15 558
Chris Bangma Netherlands 12 336 0.8× 105 0.8× 80 1.0× 30 0.4× 72 1.0× 28 547
Lisa Moris Belgium 13 281 0.7× 81 0.6× 77 1.0× 55 0.8× 72 1.0× 36 450
Takashi Fukagai Japan 14 477 1.2× 187 1.4× 81 1.0× 77 1.1× 116 1.7× 67 727
A. De La Taille France 9 499 1.2× 57 0.4× 169 2.1× 94 1.3× 94 1.4× 54 588
Crawford Ed United States 11 200 0.5× 74 0.6× 54 0.7× 18 0.3× 45 0.7× 27 334
Li Yan Khor Singapore 11 272 0.7× 114 0.9× 173 2.1× 33 0.5× 94 1.4× 36 470

Countries citing papers authored by Thomas H. Douglas

Since Specialization
Citations

This map shows the geographic impact of Thomas H. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Douglas more than expected).

Fields of papers citing papers by Thomas H. Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Douglas. The network helps show where Thomas H. Douglas may publish in the future.

Co-authorship network of co-authors of Thomas H. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas H. Douglas. A scholar is included among the top collaborators of Thomas H. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas H. Douglas. Thomas H. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Murphy, Gerald P., Haakon Ragde, Alton L. Boynton, et al.. (1998). Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Urology. 51(5). 89–97. 43 indexed citations
2.
Farley, John, Thomas H. Douglas, David G. McLeod, & Charles R. Harrison. (1998). Ureteral Carcinoma Presenting as a Complex Pelvic Mass in a Post Menopausal Patient. Gynecologic Oncology. 70(1). 134–136. 3 indexed citations
3.
Carlbom, Ingrid, Christer Busch, Thomas H. Douglas, et al.. (1998). Three-dimensional modeling of biopsy protocols for localized prostate cancer. Computerized Medical Imaging and Graphics. 22(3). 229–238. 17 indexed citations
4.
Douglas, Thomas H. & Judd W. Moul. (1998). Applications of neural networks in urologic oncology.. PubMed. 16(1). 35–9. 21 indexed citations
5.
Douglas, Thomas H., Ted O. Morgan, David G. McLeod, et al.. (1997). Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients. Cancer. 80(1). 107–114. 26 indexed citations
6.
Douglas, Thomas H., David G. McLeod, F. K. Mostofi, et al.. (1997). Prostate-specific antigen-detected prostate cancer (Stage T1c): An analysis of whole-mount prostatectomy specimens. The Prostate. 32(1). 59–64. 31 indexed citations
7.
Douglas, Thomas H., David G. McLeod, F. K. Mostofi, et al.. (1997). Prostate‐specific antigen‐detected prostate cancer (Stage T1c): An analysis of whole‐mount prostatectomy specimens. The Prostate. 32(1). 59–64. 1 indexed citations
8.
Murphy, Gerald P., Robert J. Barren, Sheila J. Erickson, et al.. (1996). Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen. Cancer. 78(4). 809–818. 52 indexed citations
9.
Moul, Judd W., Thomas H. Douglas, William F. McCarthy, & David G. McLeod. (1996). Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care Setting. The Journal of Urology. 155(5). 1667–1673. 128 indexed citations
10.
Moul, Judd W., Thomas H. Douglas, William F. McCarthy, & David G. McLeod. (1996). Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.. PubMed. 155(5). 1667–73. 138 indexed citations
11.
Moul, Judd W., Thomas H. Douglas, William F. McCarthy, & David G. McLeod. (1996). Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care Setting. The Journal of Urology. 1667–1672. 9 indexed citations
12.
Douglas, Thomas H., Roger R. Connelly, David G. McLeod, et al.. (1995). Effect of exogenous testosterone replacement on prostate‐specific antigen and prostate‐specific membrane antigen levels in hypogonadal men. Journal of Surgical Oncology. 59(4). 246–250. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per Å. Høisæter Breakdown of academic impact, for papers by W A Sakr Breakdown of academic impact, for papers by Stephen A. Brassell Breakdown of academic impact, for papers by Masatoshi Muramoto Breakdown of academic impact, for papers by Chris Bangma Breakdown of academic impact, for papers by Lisa Moris Breakdown of academic impact, for papers by Takashi Fukagai Breakdown of academic impact, for papers by A. De La Taille Breakdown of academic impact, for papers by Crawford Ed Breakdown of academic impact, for papers by Li Yan Khor
Rankless by CCL
2026